Clinical Trials Directory

Trials / Unknown

UnknownNCT03716895

Severe Septic Shock Complications

Identifying Risk Factors for Complications in Severe Septic Shock

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Adults older than 18 years old, admitted to the ICU with a Severe Septic Shock, requiring Norepinephrine at more than 0.25mcg/kg/min, who have signed informed consent form, will be consecutively included, from december 2018 to december 2019. The primary goal is to look for risk factors associated with an increased in lactate clearance Secondary goals are the following: 1. To look for risk factors associated with an increase risk of Hospital and ICU length of stay. 2. To look for risk factors associated with an increase risk of Acute Kidney Injury. 3. To look for risk factors associated with a decrease in days alive and free of Mechanical Ventilation, Vasopressors and Renal Replacement Therapy. 4. To look for risk factors associated with a decrease in Ventilator-free days. 5. To look for risk factors associated with a decrease in Vasopressor-free days. 6. To look for risk factors associated with an increase risk of in-hospital mortality. 7. To look for risk factors associated with an increase risk of Myocardial Infarction and myocardial injury. 8. To look for risk factors associated with an increase risk of Acute Respiratory Distress Syndrome. 9. To compare and validate different risk scores in our cohort.

Conditions

Timeline

Start date
2018-12-01
Primary completion
2019-12-01
Completion
2020-03-01
First posted
2018-10-23
Last updated
2018-10-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03716895. Inclusion in this directory is not an endorsement.